Compound Detail
CHEMBL492085
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL492085 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | MREXOPXRMXCFEX-JTHBVZDNSA-N |
1
Targets
2
Activities
2
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
433.6
MW (Da)
3.51
ALogP
4
HBA
2
HBD
75.4
PSA (Ų)
0.60
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 5.8
Kd 1 meas. best 6.57
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | Kd | = | 270.0 | nM | 6.57 | Inhibition of human alpha thrombin by surface plasmon resonance assay | 19371038 |
| Unchecked | IC50 | = | 1600.0 | nM | 5.8 | Inhibition of human alpha thrombin by surface plasmon resonance assay | 19371038 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 19371038 | 10.1021/jm8011849 | Unchecked | 2 |
Data from ChEMBL 36 via Core Engine